PFG Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
PFG Investments's VRTX Position: Q2 2026 in Review
PFG Investments increased its Vertex Pharmaceuticals (VRTX) stake by 4% in Q2 2026, buying an estimated $37.7K and bringing the position to 2,219 shares worth $1.1M. The position accounts for 0.04% of the portfolio, ranked #365.
PFG Investments first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- PFG Investments held 2,219 shares of Vertex Pharmaceuticals worth $1.1M as of Q2 2026.
- PFG Investments bought 85 Vertex Pharmaceuticals shares in Q2 2026, an estimated $37.7K.
- Vertex Pharmaceuticals made up 0.04% of PFG Investments's portfolio in Q2 2026, its #365 holding.
- PFG Investments first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.